Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole/Adenosine Combination vs Adenosine for Coronary Flow Reserve Assessment
NCT01593644Phase 2Unknown
- Start
- Jun 2011
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in ischemic heart disease (IHD) comparing Adenosine + Dipyridamole with Adenosine Alone (2 arms). Primary endpoint: Diastolic mean and peak coronary blood velocities at 2 minutes. Status: unknown.
02
Drugs
adenosinedipyridamole
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT01593644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593644.